Genomic landscape of MDS/CMML associated with systemic inflammatory and autoimmune disease-Reference-Cited by-同舟云学术

Genomic landscape of MDS/CMML associated with systemic inflammatory and autoimmune disease

Published:2021-02-23 Issue:9 Volume:35 Page:2720-2724
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Zhao Lin-Pierre^ORCID,Boy Maxime^ORCID,Azoulay Célia,Clappier Emmanuelle,Sébert Marie,Amable Ludivine,Klibi Jihene,Benlagha Kamel,Espéli Marion,Balabanian Karl^ORCID,Preudhomme Claude,Marceau-Renaut Alice,Benajiba Lina,Itzykson Raphaël,Mekinian Arsène,Fain Olivier,Toubert Antoine,Fenaux Pierre,Dulphy Nicolas^ORCID,Adès Lionel^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

https://www.nature.com/articles/s41375-021-01152-1.pdf

Reference15 articles.

1. Adès L, Itzykson R, Fenaux P. Myelodysplastic syndromes. Lancet. 2014;383:2239–52.

2. Mekinian A, Grignano E, Braun T, Decaux O, Liozon E, Costedoat-Chalumeau N, et al. Systemic inflammatory and autoimmune manifestations associated with myelodysplastic syndromes and chronic myelomonocytic leukaemia: a French multicentre retrospective study. Rheumatology. 2016;55:291–300.

3. Braun T, Fenaux P. Myelodysplastic syndromes (MDS) and autoimmune disorders (AD): cause or consequence? Best Pract Res Clin Haematol. 2013;26:327–36.

4. Oh Y-J, Shin D-Y, Hwang SM, Kim S-M, Im K, Park HS, et al. Mutation of ten-eleven translocation-2 is associated with increased risk of autoimmune disease in patients with myelodysplastic syndrome. Korean J Intern Med. 2020;35:457–64.

5. Fraison J-B, Mekinian A, Grignano E, Kahn J-E, Arlet J-B, Decaux O, et al. Efficacy of Azacitidine in autoimmune and inflammatory disorders associated with myelodysplastic syndromes and chronic myelomonocytic leukemia. Leuk Res. 2016;43:13–7.

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between myeloid disorders and adult onset-inflammatory syndromes, successful treatment with JAK-inhibitors: Case series and literature review;Leukemia Research;2024-11

2. Impact of spliceosome mutation on outcomes of myelodysplastic syndrome and chronic myelomonocytic leukemia patients undergoing allogeneic hematopoietic cell transplantation;Leukemia Research;2024-10

3. Molecular and clinical presentation of UBA1-mutated myelodysplastic syndromes;Blood;2024-09-12

4. Myeloid neoplasms arising after methotrexate therapy for autoimmune rheumatological diseases do not exhibit poor-risk molecular features;Blood Cancer Journal;2024-07-19

5. Predicting which subsets of patients with myelodysplastic neoplasms are more likely to progress to overt chronic myelomonocytic leukemia;Leukemia & Lymphoma;2024-07-14